首页> 外文期刊>Veterinary Parasitology >Development and evaluation of serodiagnostic assays with recombinant BgSA1 of Babesia gibsoni
【24h】

Development and evaluation of serodiagnostic assays with recombinant BgSA1 of Babesia gibsoni

机译:重组巴贝斯球菌BgSA1的血清学诊断方法的开发和评估

获取原文
获取原文并翻译 | 示例
       

摘要

Indirect ELISA, dot-ELISA and double antibody sandwich ELISA (DAS-ELISA) using truncated recombinant BgSA1 (rBgSA1) were developed for detecting Babesia gibsoni infection in naturally infected dogs. Truncated BgSA1 gene of 858 bp, encoding 32 kDa protein was cloned in pET-32a(+) expression vector, expressed in Escherichia coli and the recombinant protein was purified under native conditions. To evaluate the ability of the truncated rBgSA1 as serodiagnostic reagent for B. gibsoni infection, a panel of sera/plasma samples from dogs infected with B. gibsoni (n = 13), uninfected sera (n = 13) and sera from dogs infected with other haemoparasites namely, Babesia canis vogeli (n = 3), Ehrlichia canis (n = 3), Hepatozoon canis (n = 1) and Dirofilaria immitis (n = 1) were used. Besides these, 75 samples collected from dogs suspected for babesiosis were used to evaluate the performance of rBgSA1 based serological assays in comparison to nested PCR. Based on the results, the diagnostic sensitivity of indirect ELISA, dot-ELISA and DAS-ELISA were 97.3%, 91.9% and 100%, respectively, when nested PCR was taken as a reference test, while their specificities were 81.6%, 84.2% and 97.4%, respectively. Further, DAS-ELISA had a guantitation limit of 0.03 mu g/ml of the rBgSA1. High kappa values of indirect ELISA, dot-ELISA and DAS-ELISA were recorded, indicating that these assays had substantial to almost perfect agreement at 95% confidence level. There was no cross-reactivity with sera from dogs infected with B. canis vogeli, E. canis, H. canis and D. immitis. The results suggest that the indirect ELISA, dot-ELISA and DAS-ELISA with rBgSA1 may be used in large scale epidemiological surveys and clinical diagnosis of B. gibsoni infection in dogs. DAS-ELISA has advantages over indirect or dot-ELISA in the detection of current infection as well as monitoring the parasite burden. (C) 2014 Elsevier B.V. All rights reserved.
机译:开发了使用截短的重组BgSA1(rBgSA1)进行的间接ELISA,斑点ELISA和双抗体夹心ELISA(DAS-ELISA),用于检测自然感染犬的吉贝斯贝氏菌感染。将截短的858 bp的BgSA1基因编码32 kDa蛋白克隆到pET-32a(+)表达载体中,在大肠杆菌中表达,并在天然条件下纯化重组蛋白。为了评估截短的rBgSA1作为针对gibsoni感染的血清诊断试剂的能力,需要从被gbsoni感染的狗(n = 13),未感染的血清(n = 13)和来自感染了gbsoni的狗的血清中提取一组血清/血浆样品使用了其他血寄生虫,即犬贝贝菌(Babesia canis vogeli)(n = 3),犬埃里希(Ehrlichia canis)(n = 3),犬肝炎(Hepatozoon canis)(n = 1)和Dirofilaria炎(n = 1)。除此之外,与巢式PCR相比,从怀疑有轻度钩虫病的狗中收集了75个样本,用于评估基于rBgSA1的血清学检测的性能。根据结果​​,以巢式PCR为参考检测,间接ELISA,斑点ELISA和DAS-ELISA的诊断灵敏度分别为97.3%,91.9%和100%,而特异性为81.6%,84.2%。和97.4%。此外,DAS-ELISA的rBgSA1的胍化极限为0.03μg / ml。间接ELISA,dot-ELISA和DAS-ELISA的kappa值都很高,表明这些测定在95%的置信水平下具有基本到几乎完美的一致性。感染了犬双歧杆菌,犬双歧杆菌,犬双歧杆菌和D.乳腺炎的犬的血清与血清无交叉反应。结果表明,rBgSA1的间接ELISA,dot-ELISA和DAS-ELISA可以用于大规模的流行病学调查和犬Bibsoni感染的临床诊断。 DAS-ELISA在检测当前感染以及监测寄生虫负担方面比间接或点ELISA具有优势。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号